vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and Snap Inc (SNAP). Click either name above to swap in a different company.
Snap Inc is the larger business by last-quarter revenue ($1.7B vs $1.1B, roughly 1.5× PERRIGO Co plc). Snap Inc runs the higher net margin — 2.6% vs -127.8%, a 130.4% gap on every dollar of revenue. On growth, Snap Inc posted the faster year-over-year revenue change (10.2% vs -2.5%). Snap Inc produced more free cash flow last quarter ($205.6M vs $148.6M). Over the past eight quarters, Snap Inc's revenue compounded faster (19.9% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
Snap Inc. is an American technology company, founded on September 16, 2011, by Evan Spiegel, Bobby Murphy, and Reggie Brown, based in Santa Monica, California. The company developed and maintains technological products and services, namely Snapchat, Spectacles, Bitmoji, and SnapBoost. The company was named Snapchat Inc. at its inception, but it was rebranded Snap Inc. on September 24, 2016, to include the Spectacles product under the company name.
PRGO vs SNAP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.7B |
| Net Profit | $-1.4B | $45.2M |
| Gross Margin | 32.6% | 59.1% |
| Operating Margin | -116.0% | 2.9% |
| Net Margin | -127.8% | 2.6% |
| Revenue YoY | -2.5% | 10.2% |
| Net Profit YoY | -3093.9% | 396.7% |
| EPS (diluted) | $-10.23 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.7B | ||
| Q3 25 | $1.0B | $1.5B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.0B | $1.4B | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $1.1B | $1.4B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | $1.1B | $1.2B |
| Q4 25 | $-1.4B | $45.2M | ||
| Q3 25 | $7.5M | $-103.5M | ||
| Q2 25 | $-8.4M | $-262.6M | ||
| Q1 25 | $-6.4M | $-139.6M | ||
| Q4 24 | $-44.4M | $9.1M | ||
| Q3 24 | $-21.0M | $-153.2M | ||
| Q2 24 | $-108.4M | $-248.6M | ||
| Q1 24 | $2.0M | $-305.1M |
| Q4 25 | 32.6% | 59.1% | ||
| Q3 25 | 36.1% | 55.3% | ||
| Q2 25 | 34.4% | 51.4% | ||
| Q1 25 | 37.6% | 53.1% | ||
| Q4 24 | 33.9% | 56.9% | ||
| Q3 24 | 37.2% | 53.5% | ||
| Q2 24 | 37.0% | 52.4% | ||
| Q1 24 | 33.1% | 51.9% |
| Q4 25 | -116.0% | 2.9% | ||
| Q3 25 | 7.0% | -8.5% | ||
| Q2 25 | 4.3% | -19.3% | ||
| Q1 25 | 4.5% | -14.2% | ||
| Q4 24 | 10.0% | -1.7% | ||
| Q3 24 | 7.4% | -12.6% | ||
| Q2 24 | -2.5% | -20.5% | ||
| Q1 24 | -5.1% | -27.9% |
| Q4 25 | -127.8% | 2.6% | ||
| Q3 25 | 0.7% | -6.9% | ||
| Q2 25 | -0.8% | -19.5% | ||
| Q1 25 | -0.6% | -10.2% | ||
| Q4 24 | -3.9% | 0.6% | ||
| Q3 24 | -1.9% | -11.2% | ||
| Q2 24 | -10.2% | -20.1% | ||
| Q1 24 | 0.2% | -25.5% |
| Q4 25 | $-10.23 | $0.03 | ||
| Q3 25 | $0.05 | $-0.06 | ||
| Q2 25 | $-0.06 | $-0.16 | ||
| Q1 25 | $-0.05 | $-0.08 | ||
| Q4 24 | $-0.32 | $0.01 | ||
| Q3 24 | $-0.15 | $-0.09 | ||
| Q2 24 | $-0.79 | $-0.15 | ||
| Q1 24 | $0.01 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $2.9B |
| Total DebtLower is stronger | — | $3.5B |
| Stockholders' EquityBook value | $2.9B | $2.3B |
| Total Assets | $8.5B | $7.7B |
| Debt / EquityLower = less leverage | — | 1.55× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.9B | ||
| Q3 25 | $432.1M | $3.0B | ||
| Q2 25 | $454.2M | $2.9B | ||
| Q1 25 | $409.9M | $3.2B | ||
| Q4 24 | $558.8M | $3.4B | ||
| Q3 24 | $1.5B | $3.2B | ||
| Q2 24 | $542.8M | $3.1B | ||
| Q1 24 | $658.5M | $2.9B |
| Q4 25 | — | $3.5B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $3.6B | ||
| Q1 25 | — | $3.6B | ||
| Q4 24 | — | $3.6B | ||
| Q3 24 | — | $3.6B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.3B |
| Q4 25 | $2.9B | $2.3B | ||
| Q3 25 | $4.4B | $2.2B | ||
| Q2 25 | $4.5B | $2.1B | ||
| Q1 25 | $4.4B | $2.3B | ||
| Q4 24 | $4.3B | $2.5B | ||
| Q3 24 | $4.6B | $2.2B | ||
| Q2 24 | $4.5B | $2.1B | ||
| Q1 24 | $4.7B | $2.1B |
| Q4 25 | $8.5B | $7.7B | ||
| Q3 25 | $10.1B | $7.6B | ||
| Q2 25 | $10.1B | $7.4B | ||
| Q1 25 | $9.8B | $7.6B | ||
| Q4 24 | $9.6B | $7.9B | ||
| Q3 24 | $11.2B | $7.6B | ||
| Q2 24 | $10.4B | $7.4B | ||
| Q1 24 | $10.6B | $7.2B |
| Q4 25 | — | 1.55× | ||
| Q3 25 | — | 1.59× | ||
| Q2 25 | — | 1.73× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 1.49× | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | — | 1.76× | ||
| Q1 24 | — | 1.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $269.6M |
| Free Cash FlowOCF − Capex | $148.6M | $205.6M |
| FCF MarginFCF / Revenue | 13.4% | 12.0% |
| Capex IntensityCapex / Revenue | 2.4% | 3.7% |
| Cash ConversionOCF / Net Profit | — | 5.96× |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | $437.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $269.6M | ||
| Q3 25 | $51.7M | $146.5M | ||
| Q2 25 | $75.9M | $88.5M | ||
| Q1 25 | $-64.5M | $151.6M | ||
| Q4 24 | $312.6M | $230.6M | ||
| Q3 24 | $42.2M | $115.9M | ||
| Q2 24 | $9.5M | $-21.4M | ||
| Q1 24 | $-1.4M | $88.4M |
| Q4 25 | $148.6M | $205.6M | ||
| Q3 25 | $29.8M | $93.4M | ||
| Q2 25 | $56.7M | $23.8M | ||
| Q1 25 | $-90.0M | $114.4M | ||
| Q4 24 | $274.9M | $182.4M | ||
| Q3 24 | $15.1M | $71.8M | ||
| Q2 24 | $-18.9M | $-73.4M | ||
| Q1 24 | $-26.5M | $37.9M |
| Q4 25 | 13.4% | 12.0% | ||
| Q3 25 | 2.9% | 6.2% | ||
| Q2 25 | 5.4% | 1.8% | ||
| Q1 25 | -8.6% | 8.4% | ||
| Q4 24 | 24.2% | 11.7% | ||
| Q3 24 | 1.4% | 5.2% | ||
| Q2 24 | -1.8% | -5.9% | ||
| Q1 24 | -2.4% | 3.2% |
| Q4 25 | 2.4% | 3.7% | ||
| Q3 25 | 2.1% | 3.5% | ||
| Q2 25 | 1.8% | 4.8% | ||
| Q1 25 | 2.4% | 2.7% | ||
| Q4 24 | 3.3% | 3.1% | ||
| Q3 24 | 2.5% | 3.2% | ||
| Q2 24 | 2.7% | 4.2% | ||
| Q1 24 | 2.3% | 4.2% |
| Q4 25 | — | 5.96× | ||
| Q3 25 | 6.89× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 25.34× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
SNAP
| Advertising Revenue | $1.5B | 86% |
| Other Revenue | $231.9M | 14% |
